Hector Alilia | Venture Partner for Industry Alliance

Dr. Alila has more than 30 years of senior management experience in drug development in large pharmaceutical and biotech companies and academic research.

Prior to his role as President and CEO of Esperance Pharmaceuticals, Dr. Alila served as Senior Vice President of Drug Development at Protalex, Inc. in New Hope, Penn., Vice President of Product Development at Cell Pathways Inc. in Horsham, Penn., Director of Biology/Pharmacology at GeneMedicine, Inc. in The Woodlands, Texas, and R&D positions at SmithKline Beecham (now GlaxoSmithKline) in Pennsylvania.

He has published over 40 scientific papers in peer-reviewed journals, two book chapters and holds 12 issued patents.

Dr. Alila obtained his Ph.D. in physiology and immunology from Cornell University, where he also held a faculty position as Senior Research Associate in Physiology at the Veterinary College. He earned his veterinary degree from the University of Nairobi, Kenya, and continued his training at University of Pennsylvania to become a licensed veterinarian to practice in Pennsylvania and New York.